Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial - The Lancet
4.7
$ 8.99
In stock
(445)
Product Description
Microorganisms, Free Full-Text
Tuberculosis - The Lancet
Evaluation of two short standardised regimens for the treatment of
Long-term treatment outcomes in patients with multidrug-resistant
PDF] Economic evaluation of short treatment for multidrug
Estimating post-treatment recurrence after multidrug-resistant
Optimizing (O) rifapentine-based (RI) regimen and shortening (EN
Jornal Brasileiro de Pneumologia - Shortened tuberculosis
The pipeline of new molecules and regimens against drug-resistant
PDF) Investigation of the efficacy of the short regimen for
Efficacy of integrating short-course chemotherapy with Chinese
Real-world experience of adverse reactions-necessitated rifampicin
Jornal Brasileiro de Pneumologia - Shortened tuberculosis
Evaluation of two short standardised regimens for the treatment of
